Actively Recruiting
Feasibility of Group-Based Metacognitive Therapy for PTSD
Led by Karolinska Institutet · Updated on 2025-12-24
30
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
R
Region Stockholm
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this study is to investigate the feasibility and acceptability of group-based Metacognitive Therapy (MCT) for post-traumatic stress disorder (PTSD) when delivered within routine psychiatric care in Sweden. The secondary objective is to evaluate preliminary treatment effects of group-based MCT on symptoms of post-traumatic stress, complex PTSD, depression, and quality of life, and to compare treatment dropout rates to those reported in the existing literature on exposure-based treatments for PTSD.
CONDITIONS
Official Title
Feasibility of Group-Based Metacognitive Therapy for PTSD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Fulfills the diagnostic criteria for PTSD based on clinical records
- Self-rated total sum score over 30 on the PCL-5
- Age 65 18 years
- Stable psychotropic medication regimen for 65 4 weeks
- Fluent in Swedish
You will not qualify if you...
- Severe psychiatric comorbidities such as suicidal ideation, active psychosis, or bipolar disorder requiring immediate attention
- Current trauma-related threat such as ongoing domestic violence
- Ongoing evidence-based trauma-focused psychological treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst
Stockholm, Sweden, 14157
Actively Recruiting
Research Team
M
Maria Bragesjö
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here